FDA FDA 510(k) clearance: Helo Max Thrombectomy System (HEL2090) — K261800, Sep 3, 2026. Applicant at approval: Endovascular Engineering. source ↗
FDA FDA 510(k) clearance: Helo Thrombectomy System — K252956, Dec 18, 2025. Applicant at approval: Endovascular Engineering, Inc. source ↗
FDA records (last 2 years)
FDA 510(k) clearance: Helo Max Thrombectomy System (HEL2090) — K261800, Sep 3, 2026. Applicant at approval: Endovascular Engineering. source ↗
FDA 510(k) clearance: Helo Thrombectomy System — K252956, Dec 18, 2025. Applicant at approval: Endovascular Engineering, Inc. source ↗
NIH awards 1
Annual award amounts. Total $298K.
NIH award 1R43HL160292-01 FY2021: $298,197 awarded for that fiscal year; activity R43 (SBIR); PI ROSENTHAL, MICHAEL; recipient as written: ENDOVASCULAR ENGINEERING, INC., MENLO PARK, CA. Enhanced Suction Thrombectomy source ↗
